FTC Goes After PBMs, Warns Of Legal Action
Forbes Last month, the Federal Trade Commission (FTC) voted unanimously (5-0) to examine rising list prices of insulin, but also to probe...
top of page
Newswire
Search
PUTT
4 min
Lawmakers ask GAO to probe pharmacy benefit managers over their role in drug pricing
STAT News Amid intensifying scrutiny of pharmacy benefit managers, a group of House Republicans is urging the U.S. Government...
41 views0 comments
PUTT
7 min
FTC Probe Into Rx Middlemen May Spark Industry Shakeup
Law360 Concerns that pharmaceutical middlemen inflate drug prices and harm patients have led the Federal Trade Commission to launch a...
51 views0 comments
PUTT
20 min
Senate Commerce Committee Issues Testimony From David A. Balto Law Offices Antitrust Attorney
The Senate Commerce, Science and Transportation Committee issued the following testimony by David A. Balto, antitrust attorney at David...
19 views0 comments
PUTT
6 min
Prospect of lower fees for prescription drugs could be dashed by new maneuver from PBMs
The Columbus Dispatch A few months ago, proposed federal action to reduce fees on prescription drugs used by millions of older Americans...
27 views0 comments
PUTT
3 min
Provider status is very necessary for pharmacists (and I will argue with AMA later on this)
James Lott, CEO of Script Health in Chicago, strongly favors the Pharmacy and Medically Underserved Areas Enhancement Act, the bill that...
19 views1 comment
PUTT
9 min
Vertically integrated payer-provider groups raise antitrust concerns
Modern Healthcare More commercial insurers are overhauling their business models in response to changes ushered in by the Affordable Care...
102 views0 comments
PUTT
2 min
While UnitedHealth Reports $24B in Profits, Americans Faced 200% Increases in Out-of-Pocket Costs
No insurer has ever made that kind of money in U.S. history. Wendell Potter NOW Just days after a Commonwealth Fund report showed that...
7 views0 comments
We Need Your Support Today!
bottom of page